Pharmacodynamic Evaluation of Irinotecan Therapy by FDG and FLT PET/CT Imaging in a Colorectal Cancer Xenograft ModelSarah R. Mudd, Yanping Luo, Kimberley D. Holich et al.|Molecular Imaging and Biology|2011Cited by 19
Abstract 4718: ABBV-075, a novel BET family bromodomain inhibitor, represents a promising therapeutic agent for a broad spectrum of cancer indicationsAparna V. Sarthy, Yu Shen, Mai H. Bui et al.|Cancer Research|2016Cited by 10
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft modelSarah R. Mudd, Mark L. Day, Martin J. Voorbach et al.|Cancer Chemotherapy and Pharmacology|2012Cited by 5